| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |